Loading...
Home Page 2017-12-21T13:35:06+00:00

Agili-C™ IDE Clinical Study

Our pivotal study will include US and OUS centers, with the aim of evaluating the safety and effectiveness of Agili-C™ compared to current surgical standard of care in traumatic and arthritic lesions. The study is designed as prospective, multicenter, open-label, randomized and controlled. It will be conducted in accordance with FDA regulations, Declaration of Helsinki, and Good Clinical Practice (GCP) guidelines, and in compliance with the applicable local regulations.

Read More
agili
Am I eligible?

Am I eligible?

Find out if you may be a potential participant in the Agili-C™ IDE Clinical study

Answer questionnaire

Refer a patient

Find out if Agili-C™ might be a potential treatment for your patients

Healthcare Professionals
Refer a patient
Am I eligible?

Am I eligible?

Find out if you may be a potential participant in the Agili-C™ IDE Clinical study

Answer questionnaire
Refer a patient

Refer a patient

Find out if Agili-C™ might be a potential treatment for your patients

Healthcare Professionals